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Abstract Purpose: To ascertain
the relationship among early (first
48 h) deep sedation, time to extuba-
tion, delirium and long-term
mortality. Methods: We conducted
a multicentre prospective longitudinal
cohort study in 11 Malaysian hospi-
tals including medical/surgical
patients (n = 259) who were sedated
and ventilated C24 h. Patients were
followed from ICU admission up to
28 days in ICU with 4-hourly seda-
tion and daily delirium assessments
and 180-day mortality. Deep sedation
was defined as Richmond Agitation
Sedation Score (RASS) B-3.
Results: The cohort had a mean
(SD) age of 53.1 (15.9) years and
APACHE II score of 21.3 (8.2) with
hospital and 180-day mortality of 82
(31.7 %) and 110/237 (46.4 %).
Patients were followed for 2,657 ICU
days and underwent 13,836 RASS
assessments. Midazolam prescription
was predominant compared to pro-
pofol, given to 241 (93 %) versus 72
(28 %) patients (P \ 0.0001) for 966
(39.6 %) versus 183 (7.5 %) study
days respectively. Deep sedation
occurred in (182/257) 71 % patients
at first assessment and in 159 (61 %)
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patients and 1,658 (59 %) of all
RASS assessments at 48 h. Multi-
variable Cox proportional hazard
regression analysis adjusting for a
priori assigned covariates including
sedative agents, diagnosis, age,
APACHE II score, operative, elec-
tive, vasopressors and dialysis
showed that early deep sedation was
independently associated with longer
time to extubation [hazard ratio (HR)
0.93, 95 % confidence interval (CI)
0.89–0.97, P = 0.003], hospital death
(HR 1.11, 95 % CI 1.05–1.18,
P \ 0.001) and 180-day mortality
(HR 1.09, 95 % CI 1.04–1.15,
P = 0.002), but not time to delirium
(HR 0.98, P = 0.23). Delirium
occurred in 114 (44 %) of patients.
Conclusion: Irrespective of sedative
choice, early deep sedation was
independently associated with
delayed extubation and higher mor-
tality, and thus was a potentially
modifiable risk in interventional
trials.
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Introduction
Sedation is an integral part of intensive care practice to
minimise patient discomfort and anxiety, facilitate
mechanical ventilation and allow essential intensive care
procedures [1, 2]. Complications associated with seda-
tive prescription and in particular deep sedation with
adverse outcomes have been well described [3, 4].
Reports of shorter ventilation time, shorter ICU stay and
attenuation of delirium with protocols targeting light
sedation [5–8] highlight the need to avoid deep sedation
proactively [9].
There are no reliable data on the compliance of
intensive care clinicians with published guidelines or the
implementation of protocols to promote light sedation
[10]. A meta-analysis has reported that most sedation
trials failed to achieve optimal sedation, and more than
two-thirds of studies reported inappropriate deep sedation
[11]. Sedation practice surveys did not assess patients
longitudinally and are therefore unable to draw conclu-
sions on the incidence of deep sedation or its association
with relevant outcomes [12–14].
Randomised clinical trials and observational cohort
studies have largely not accounted for the early pre-
scription of sedative agents or the early depth of sedation,
in particular in the first 48 h after the initiation of
mechanical ventilation. Early deep sedation is therefore a
risk factor that may be overlooked while clinicians’
attention focuses on more pressing issues and priorities.
The occurrence of early deep sedation, therefore, can
have a significant confounding effect on the results of
sedation trials if not taken into consideration.
The Australian New Zealand sedation practice in
intensive care evaluation (ANZ SPICE) study [15]
revealed that early sedation depth predicts important
outcomes such as mortality. To assess the strength of this
relationship outside an ANZ model of care, we replicated
the ANZ SPICE in Malaysian ICUs. In this prospective,
longitudinal, multicentre cohort study, we assessed cur-
rent sedation practice and the prevalence of deep sedation,
particularly early after initiation of mechanical ventila-
tion, and quantified the relationship between early deep
sedation and important clinical outcomes including time
to extubation, delirium and hospital and 180-day
mortality.
Materials and methods
Study design and process
We conducted a multicentre, prospective, longitudinal,
observational, non-interventional cohort study in 11 ICUs
(8 public, 2 university and 1 tertiary specialist centres) in
Malaysia from March to July 2011 using the ANZ SPICE
protocol [15]. All participating ICUs were managed by
full-time intensivists and/or anaesthesiologists with a 24/7
on-duty senior medical officer. In ventilated patients, the
nurse:patient ratio was 1:2 in most ICUs. The study was
approved by The National Medical Research Register and
consent waived by the institutional ethics committee at
participating sites.
The study was conducted in collaboration with the
ANZ Intensive Care Research Centre (ANZIC RC) and
the Monash University Centre for Clinical Research
Excellence in Therapeutics. A streamlined case report
form with Optical Recognition Software was used and
sent to the ANZIC RC for data entry, data queries and
analysis.
Inclusion and exclusion criteria
Patients were included if they had been ventilated within
the previous 24 h, were receiving continuous or inter-
mittent sedative and/or analgesic medication and were
expected to be ventilated for longer than 24 h. Patients
were excluded if they were \18 years, had proven or
suspected neurological impairment, psychiatric illness,
burns, dementia, palliative care or were unable to
communicate with carers/investigators because of lan-




Principal investigators, research staff and senior nurses at
each participating centre were trained in the study pro-
cedures, including bedside twin assessment of patients
using the Richmond Agitation and Sedation Scale (RASS)
[16] and the confusion assessment method for intensive
care (CAM-ICU) [17]. Assessors were allowed to use
local dialects (English, Malay, Hindi, Mandarin or Can-
tonese) to communicate with patients. To conduct the
inattention (feature II) part of the CAM-ICU in patients
who had difficulty with the alphabet, numbers were used
(ten random numbers where the number 3 was repeated
four times) instead of the (SAVEAHAART) phrase [18].
CAM-ICU was conducted ONLY if patients were in a
RASS range of -2 to ?1 (lightly sedated).
Definitions and data collection methods
Relevant baseline demographic data including hospital
and ICU admission details and Acute Physiology and
Chronic Health Evaluation II (24-h APACHE II) scores
were collected [19].
Patients were followed from ICU admission to ICU
discharge or 28 days in the ICU, which ever came first.
The first 48 h following initiation of mechanical ventila-
tion was considered ‘‘early’’ and [48 h the ‘‘subsequent’’
period. RASS was assessed every 4 h and CAM-ICU
assessed daily by trained nurses or principal investigators.
Patients in a RASS range of -2 to ?1 were considered
lightly sedated, RASS range of -3 to -5 deeply sedated
and [2 agitated. Patients were considered delirious if the
CAM-ICU was positive. Patients were considered coma
and delirium free if they had a RASS above -3 with a
negative CAM-ICU score. Administration details and
dosage of all sedative, analgesic and adjunct medications
(intravenous infusion or bolus) were collected daily.
Survival status at ICU and hospital discharge and at 180
days was collected. Only patients who reside in Malaysia
were followed for 180-day mortality.
Statistical analysis
The statistical analysis was modelled on that used in the
ANZ SPICE [15] and independently conducted at the
ANZIC RC, Monash University, Centre for Clinical
Research Excellence in Therapeutics.
Sample size
Based on the ANZIC SPICE data, 260 patients would
have 90 % power with a two-sided p value of 0.05 to
detect a difference of 2 in the number of times deep
sedation was reported in the first 48 h between patients
who died or survived. This would also allow 80 % power
to identify point estimates within 5 % of the true value of
an event assuming it occurred in 10 % of patients.
Statistical analysis
All patients were included in the analysis. Comparisons of
proportions were performed using chi-square tests for
equal proportions or Fisher’s exact tests where appropri-
ate. Normally distributed continuous variables were
compared using Student’s t tests. Non-normally distrib-
uted variables were compared using Wilcoxon rank-sum
tests.
RASS scores were treated as ordinal data; however,
the RASS range of deep sedation (-3 to -5) was con-
sidered a continuous variable with every additional RASS
level in the deep sedation range adding to the intensity of
sedation depth. Early deep sedation was the primary
exposure variable in the time to event analysis of out-
comes occurring after 48 h: time to extubation, time to
subsequent delirium, time to hospital death and 180-day
mortality. Time to event analysis was performed using
Cox proportional hazard regression and reported as haz-
ard ratios (95 % CI) and as Kaplan-Meier curves with a
corresponding log-rank test. All patients with an ICU stay
greater than 48 h were included in the Kaplan-Meier
estimates with conventional censoring at the time of
death. Adjustment of observed effects due to known or
suspected potential confounders was undertaken using
multivariable analysis using a list of a priori defined
covariates comprising APACHE III diagnosis (cardiac,
respiratory, gastrointestinal, sepsis or other), age, sex,
APACHE II score, operative admission (surgical), elec-
tive admission and the cumulative doses of midazolam
and dexmedetomidine, and the use of vasopressors and
dialysis within the first 48 h of admission. All patients
with ICU lengths of stay less than 48 h were excluded
from the multivariate analysis. A two-sided p value of
0.05 was considered to be statistically significant. Anal-
ysis was performed using SAS version 9.2 (SAS Institute
Inc., Cary, NC, USA) and STATA version 11.0 (Stata-
Corp LP College Station, TX, USA).
Results
Patients’ demographics and baseline characteristics
We enrolled 259 patients; the main source of admission
was from the general ward and emergency department
(166) 64 %, with only (35) 13.5 % of patients admitted
after elective surgery. Mortality at 6 months was 46.4 %;
loss to follow-up occurred in (22) 8.5 % patients. Base-
line demographics and clinical characteristics for the
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primary cohort and for patients who were lightly sedated
versus those who were deeply sedated at 48 h are shown
in Table 1.
Sedative and analgesic prescription
Overall therapy
Patients were followed up to a total of 2,657 ICU days, of
which 72.8 % (1,935) were ventilated days and 91.8 %
(2,439) days in which sedative and/or analgesic medica-
tions were administered. Midazolam was the predominant
sedative agent given to 93 % (241) of patients on 39.6 %
(966) of study days. Propofol prescription was signifi-
cantly less and only given to 74 (28 %) (P \ 0.0001
compared with midazolam) of patients on 7.5 % (183) of
study days. The primary analgesics used were morphine
and fentanyl in 77.6 % (199) and 60.2 % (156)
(P \ 0.001) of patients respectively. Dexmedetomidine
was given to 29.3 % (76) of patients. Adjunct medications
such as haloperidol, diazepam and ketamine were
uncommonly used in 8.9 % (21), 2.3 % (6) and 5.8 %
(14) of patients respectively.
Prescription over first 48 h
In the 48 h following initiation of mechanical ventilation,
most patients received midazolam [88.4 % (229)] and/or
morphine [71.4 % (185)] and/or fentanyl [40.5 %(105)].
Dexmedetomidine and propofol were given to 16.2 %
(42) and 10 % (26) of patients respectively. Table 2
shows the sedative, analgesic and adjunct drug adminis-
tration in the first 48 h and throughout the study period
including cumulative per patient, per day dosage and the
number of prescription days for each agent.
Early and subsequent sedation level
Over a total of 2,657 ICU study days, 13,836 RASS
assessments were made. At first assessment, 71 % (182/
257) of patients were in the deep sedation range (RASS
-3 to -5). Of all RASS assessments conducted early
(first 48 h), 58 % (1,658) were in the deep sedation range,
39.3 % (1,124) in the light sedation range (-2 to ?1) and
2.8 % (80) in the RASS range of 2–4. During the first
48 h after initiation of mechanical ventilation, the median
(IQR) of all RASS scores was -3 [-4-(-1)]. At the end
of 48 h, 61 % (159) of patients were still deeply sedated.
After 48 h and subsequently throughout the study
period, the median (IQR) RASS scores were -1 [-3-0],
with 34 % (4,528/13,319) of RASS assessments in the
deep sedation range, 62.4 % (8,311/13,319) in the lightly
sedated range, and only 3.5 % (466/13,319) RASS
assessments were between 2 and 4. There was a signifi-
cant difference in the intensity of sedation scored in the
first 48 h compared with subsequent study days (Fig. 1).
The main reported indications for deep sedations were
controlled ventilation 64.9 % (288/444) and concurrent
muscle relaxation and severe agitation 35.1 % (156/444)
of days where an indication for deep sedation was pres-
ent. Clinicians prescribed a sedation target on 22.8 %
Table 1 Patients’ demographics and clinical characteristics
Patients’ characteristics Primary cohort
(n = 259)






Age, mean (SD), years 53.1 ± 15.9 53.6 ± 13.9 53.2 ± 16.3 0.87
Male (n) % (162) 62.5 % (25) 55.5 % (134) 64.1 % 0.28
Weight, mean (SD), kg 68.2 ± 19.8 72.7 ± 22.2 67.4 ± 19.4 0.10
APACHE II score, mean (SD) 21.3 ± 8.2 20.1 ± 7.8 21.6 ± 8.3 0.24
Operative admission diagnosis (n) % (83) 32.0 % (18) 40.7 % (65) 31.1 % 0.25
Respiratory failure admission diagnosisa (n) % (66) 25.5 % (13) 28.9 % (51) 24.4 % 0.53
Cardiovascular admission diagnosisa (n) % (39) 15.4 % (11) 24.4 % (29) 13.9 % 0.08
Vasopressors infusions (n) % (209) 80.7 % (28) 62.2 % (164) 78.4 % 0.021
Renal replacement therapy (n) % (73) 28.2 % (7) 15.6 % (43) 20.6 % 0.44
Tracheostomy after ICU admission (n) % (36) 14 % (7) 15.6 % (28) 13.4 % 0.71
Time to tracheostomy, median (IQR) days 9.35 (5.63–15.34) 11 (5.67–16) 9.35 (5.63–13.7) 0.86
Ventilation days, median (IQR) 4.96 (2.99–8.8) 3.95 (2.7–6.9) 6.69 (4–11.7) 0.008
28-Day coma and delirum-free days 24 (0–26) 28 (26–28) 23 (0–26) \0.0001
ICU length of stay, median (IQR) days 7.19 (4.8–11) 6.52 (4.83–6.69) 7.7 (4.95–11.57) 0.35
Hospital length of stay, median (IQR) days 16.4 (10.0–30.7) 17.6 (12.7–32.2) 16.5 (9.5–28.9) 0.08
ICU mortality (n) % (66) 25.5 % (3) 6.7 % (63) 30.1 % 0.001
Hospital mortality (n) % (82) 31.7 % (6) 13.4 % (76) 36.4 % 0.003
180-day mortality (n) % (110/237) 46.4 % (10/41) 24.4 % (100/192) 52.1 % 0.001
n Number, SD standard deviation, IQR interquartile range, APACHE II Acute Physiologic Assessment and Chronic Health Evaluation
a APACHE III diagnostic codes [19]
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(3,074/13,481) of occasions, and the target was achieved in
47 % (1,446) of assessments. Deliberate cessation of all
sedatives and analgesics occurred on 20 % (485/24,240) of
study days; however, routine daily sedation interruption
was rarely implemented in only 2.3 % (56) of days.
Throughout the study period, neuromuscular blockers
were used on 4.1 % (100) of ICU days, while physical
restraints were used on 21.1 % (515) of days. Self extu-
bation was recorded in 0.4 % (10) of episodes.
Occurrence of delirium
Delirium (positive CAM-ICU during RASS -2 to ?1)
was reported in 27.4 % (20/73) of patients at first
assessment and in 44 % (114) of patients throughout the
study period for a median (IQR) of 2 (1–4) days. In
patients who stayed [8 days in the ICU, delirium was
present in 50 % (33/66) and 68.9 % (31/45) of patients
who stayed in the ICU longer than 14 days. Coma and
delirium-free days at 28 days were significantly more in
patients lightly sedated in the first 48 h (Table 1).
Early sedation depth and clinical outcomes
Kaplan-Meier estimates showed that the patients who
were deeply sedated at 48 h had a significantly longer
time to extubation (log-rank P = 0.008) (Fig. 2) and
higher hospital (log-rank P = 0.004) and 180-day mor-
tality (log-rank P = 0.001) (Fig. 3). Univariate analysis
showed that time to delirium after 48 h was also signifi-
cantly shorter with early deep sedation (OR 0.64 95 % CI
0.57–0.73, P \ 0.001).
Multivariable Cox proportional hazard regression,
adjusted for relevant covariates (Table 3), showed that the
occurrence of every additional RASS in the -3 to -5
range was independently associated with a reduced
chance of shorter time to extubation (HR 0.93, 95 % CI
0.89–0.97, P = 0.0001), hospital death (HR 1.11, 95 %
CI 1.04–1.18, P \ 0.001) and 180-day mortality (HR
1.10, 95 % CI 1.04–1.15, P = 0.002). Trend analysis
using the Cochran-Mantel-Haenszel test showed that
these associations were approximately linear (0.03). Early
deep sedation was not associated with time to delirium
occurring after 48 h (HR 0.98, P = 0.46).
Multivariable analysis with hospital mortality showed
that early deep sedation (HR 1.13, 95 % CI 1.06–1.20,
P \ 0.0001), APACHE II (HR 1.04, 95 % CI 1.00–1.08,
P = 0.04) and a cardiac admission diagnosis (HR 3.51,
95 % CI 1.31–9.44, P = 0.01) were associated with
hospital mortality.
Adjusted multivariable analysis also showed that the
cumulative dose of midazolam in the first 48 h was
associated with the RASS -3 to -5, but it was not
Table 2 Sedative, analgesic and adjunct medications given













Midazolam (mg) 389 (75.1 %) 28 (12–58) 966 (39.6 %) 31 (12–66) 3.37 (3.4)
Propofol (mg) 36 (6.9 %) 240 (100–680) 183 (7.5 %) 350 (100–800) 0.71 (1.4)
Morphine (mg) 327 (63.1 %) 24.5 (12.54) 773 (31.7 %) 25 (10–51) 2.99 (3.23)
Fentanyl 168 (32.4 %) 290 (95–620) 771 (31.6 %) 450 (200–780) 2.97 (4.19)
Dexmedetomidine 65 (12.5 %) 1.93 (0.9–4.3) 334 (13.7 %) 3.96 (1.98–7.2) 1.29 (2.67)
Ketamine (mg) 16 (3.1 %) 390 (157–750) 46 (1.9 %) 1,374 (315–3,840)c 0.18 (0.84)
Haloperidol (mg) 6 (1.2 %) 7.5 (2.2–13.5) 51 (2.1 %) 15 (5–46)c 0.19 (0.79)
Diazepam (mg) 2 (0.4 %) 4.2 (2.2–6) 20 (0.8 %) 21 (10–15)c 0.08 (0.69)
a Cumulative median (IQR) dose mg (when stated), lg (dexmedetomidine and fentanyl) patient-1 day-1
b Mean (SD)
c Cumulative dose patient-1
Fig. 1 RASS assessments during early (first 48 h) and subsequent
study days. During the first 48 h following initiation of mechanical
ventilation, 2,859 RASS assessments were conducted, of which
58 % (1,658) were in the -3 to -5 range compared to 34 % (4,258/
13,319) in the -2 to ?1 range (P \ 0.0001). There was a
significant increase in the RASS score of 0 (Calm) after the first
48 h [(4,688/13,319) 35.2 % versus (323) 11.3 % (P \ 0.0001) in
the first 48 h]
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associated with time to extubation, delirium or death.
The cumulative dose of dexmedetomidine in the first
48 h, however, was significantly associated with delayed
time to delirium occurring after 48 h (HR 1.41 95 % CI
1.13–1.76, P = 0.002).
Discussion
Main findings
We identified a significant independent relationship
between the intensity of sedation in the first 48 h (early)
after initiation of mechanical ventilation and important
clinical outcomes. Early deep sedation was independently
associated with time to extubation and mortality. The
occurrence of every additional RASS assessment in the
deep sedation range was associated with a 13 % increase
in the risk of death at hospital discharge (and 10 % at
6 months) and a 7 % delay in extubation (8.5 h). All these
associations remained significant after adjusting for
multiple covariates including sedative choice, admission
diagnosis and severity of illness.
We also found that midazolam and morphine were the
most commonly used agents for sedation and analgesia in
Malaysian ICUs for patients ventilated for longer than
24 h, and the use of propofol was less frequent.
Fig. 2 Kaplan-Meier curves for
time to extubation. Time to
extubation was significantly
longer amongst patients who
were deeply sedated early
compared with those that were
not. Median (IQR) time to
extubation was 3.95 (2.7–6.9)
versus 6.69 (4–11.7) days (log-
rank P \ 0.008)
Fig. 3 Kaplan-Meier curves for
180-day mortality. Those who
were deeply sedated early (first
48 h) showed a significant
increase in risk of death at
6 months (log-rank P = 0.001)
compared with patients who
were not deeply sedated
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Other studies on sedation-related outcomes
Our findings are consistent with findings of the ANZ
SPICE study [15] cohort and lend strong support to the
notion that early deep sedation is an important and
potentially modifiable risk factor for delayed time to
extubation and increased mortality. Furthermore, our
results suggest that these findings are neither confined to
an ANZ ICU model of care nor determined by a particular
sedative regimen. Thus, it is plausible that these findings
are generalisable to a wider intensive care setting and that
early deep sedation may be a global problem associated
with poor outcome.
Patients enrolled in this cohort have similar charac-
teristics to patients recruited in the ANZ SPICE study [15]
and in other observational [20] and interventional studies
[21, 22] with a high APACHE II score and primarily
medical diagnoses with standard ICU interventions. The
intensity of sedation depth reported at enrolment, early
and throughout the study period is comparable to that
reported in the ANZ SPICE [15] study. All of this pro-
vides external validity and confidence that our findings
may be applicable to similar cohorts.
Randomised trials of sedation practice have largely
ignored this early period following initiation of mechanical
ventilation and do not account for sedation practice and
sedation depth prior to randomisation. In the largest seda-
tion trials published so far, including the most recent
randomised twin trials of sedation [23, 24], patients were
randomised up to 72–96 h after ICU admission, potentially
limiting the full treatment effect of the interventions tested.
Our study is the first to report the incidence of delir-
ium in Malaysian ICUs. Although the CAM-ICU was
only assessed during light sedation, 44 % of patients
developed an episode of delirium. It is possible that
delirium was underdiagnosed in our cohort; however, our
patients were on average a few years younger than those
in ANZ SPICE, inferring a lower risk of delirium.
Although reduced sensitivity of the CAM-ICU has been
reported [25, 26], delirium was methodologically and
diligently assessed in our cohort by trained research and
study staff. While sedative induced coma is believed to
increase the risk of delirium [27], we did not find early
deep sedation or the cumulative dose of sedative agents to
independently predict time to delirium. Dexmedetomidine
given in the first 48 h, however, independently predicted
delayed time to delirium occurring after 48 h.
Studies of sedation depth
Reducing overall deep sedation has been shown to improve
a variety of clinical outcomes. Strategies to reduce sedation
depth included sedation interruption [5], protocolised
sedation [6, 8, 28] and analgo-sedation [7]. All appear to
lead to shorter ventilation time, attenuation of delirium and
trend to reduced mortality. It is important, however, to
implement strategies to reduce sedation depth early after
initiation of mechanical ventilation. This would be more
challenging in the context of a randomised clinical trial.
The practice of daily sedation interruption was not
common in our cohort. Multiple reports [21, 22, 29]
questioned the utility of routine sedation interruption
where sedation algorithms are routinely used.
Our study supports the need for an adequately powered
process of care sedation trial that addresses the problem of
early deep sedation. This can be achieved through early
delivery of interventions, which are likely to reduce the
intensity of early and subsequent sedation while providing
comfort and safety to patients. Such interventions may
Table 3 Multivariable proportional hazard Cox regression of time to extubation, delirium and 180-day mortality versus early sedation
depth (RASS -3 to -5) as primary exposure variable
Time to extubation Delirium after 48 h 180-Day mortality
HR 95 % CI P HR 95 % CI P HR 95 % CI P
RASS -3 to -5a 0.93 0.89–0.96 0.0001 0.98 0.94–1.03 0.46 1.10 1.04–1.15 0.0002
APACHE IIb 0.96 0.94–0.98 0.001 0.98 0.96–1.01 0.22 1.02 0.10–1.05 0.08
Age 1.00 0.99–1.01 0.77 1.01 1.00–1.03 0.04 1.02 1.00–1.03 0.01
Male 0.84 0.61–1.16 0.29 1.37 0.92–2.04 0.12 0.75 0.50–1.14 0.17
Operative 1.22 0.74–2.04 0.43 1.10 0.60–1.03 0.75 0.56 0.26–1.21 0.14
Elective 0.99 0.54–1.79 0.96 1.31 0.65–2.64 0.44 0.83 0.32–2.13 0.70
Cardiacc 0.84 0.47–1.50 0.56 1.17 0.59–2.32 0.66 2.22 0.92–5.36 0.07
Respiratoryc 0.82 0.51–1.31 0.41 0.94 0.51–1.73 0.84 1.14 0.57–2.29 0.71
Sepsisc 0.97 0.59–1.60 0.91 1.22 0.65–2.31 0.54 1.22 0.59–2.50 0.60
Gastrointesc 0.61 0.33–1.12 0.11 0.94 0.46–1.90 0.86 2.42 1.02–5.75 0.04
Vasopressors 1.09 0.73–1.64 0.67 1.15 0.70–1.94 0.54 1.42 0.81–2.47 0.22
Dialysisd 0.53 0.32–0.86 0.01 1.03 0.60–1.76 0.92 0.94 0.94–2.45 0.09
a For every additional RASS in deep sedation, chance of achieving
the desired outcome (shorter time to extubation) was reduced by
7 % (4–11 %)
b Acute Physiologic Assessment and Chronic Health Evaluation II
c APACHE III admission diagnostic codes
d Vasopressors and any form of dialysis within the first 48 h
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combine the use of agents known to promote light cooper-
ative sedation such as propofol [30] or dexmedetomidine
[23, 24] with targeted light sedation. Importantly, future
trials should assess long-term patient-centred outcomes such
as mortality and cognitive function as the main outcomes.
Strengths and limitations
The primary strengths of our study were the detailed and
comprehensive assessment of patients from ICU admis-
sion (including the crucial first 48 h) to 28 days and an
180-day follow-up. This is the first study of this nature to
be conducted outside the developed world; however, the
study was supported by an experienced research methods
centre and centrally coordinated and monitored; thus, the
data quality was high. Robust statistical methods assess-
ing time-to-event analysis using multivariate Cox
proportional hazard regression adjusting for a priori
selected covariates were used. Cohort studies, however,
cannot establish causation, and unmeasured confounders
could not be adjusted for in the statistical model.
Conclusion
In mechanically ventilated critically ill patients with
mainly medical ICU admission diagnoses, the intensity of
sedation in the first 48 h after initiation of mechanical
ventilation was independently associated with time to
extubation and mortality. These findings strengthen the
premise that early sedation depth is a potentially modifi-
able target to improve important clinical outcomes and a
universal problem in intensive care sedation worldwide.
Future sedation trials should account for the choice of
sedative agents and sedative delivery shortly after initia-
tion of mechanical ventilation.
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